Italy-based orthopaedic devices company Demetra has acquired OrthoFundamentals, a US-based provider of advanced implants and single-use instrument kits for SI Joint Fusion.
In relation to the acquisition, the Italian company is launching its new business unit, Demetra Spine, dedicated to advancing spinal surgery with value-based solutions.
OrthoFundamentals is focused on reducing the cost of orthopaedic care by enhancing efficiencies throughout the patient journey.
The company offers a suite of implants and procedural kits tailored to the needs of outpatient Ambulatory Surgery Centres (ASCs).
It leverages additive manufacturing methods and novel surface treatments to enhance osteointegration, focusing on innovation to reduce costs.
OrthoFundamentals founder and CEO Matthew Palmer said: “There was a natural synergy and shared vision between OrthoFundamentals and Demetra to differentiate in the market by addressing the primary pain points experienced by providers of spine surgical solutions, particularly in the outpatient ASC settings.
“We are excited to join the Demetra Spine team and accelerate this vision to lead by being fundamentally different with single-use solutions that are Always Sharp, Always Sterile and Always Ready.”
The acquisition of OrthoFundamentals follows Demetra’s recent strategic efforts to enhance its spine surgery offerings.
The efforts include acquiring a majority stake in GetSet Surgical, a Swiss producer of sterile-packed single-use spine procedure kits.
Additionally, Demetra purchased assets from Bespoke Technologies, which provides 3D-printed titanium implants for ACDF procedures.
Demetra CEO Michele Perrino said: “This move represents a bold step in Demetra’s strategy to revolutionise spinal care through innovation, sustainability, and clinical effectiveness.
“Our ambition is to become the company of choice also in spinal care by developing breakthrough technologies that lower infection risk and set new standards for surgical innovation.
“The appointment of Ted Bird to lead the Demetra US Spine Division is a powerful statement of intent. His extensive global commercial leadership experience and deep expertise across orthopaedics, spine, neurosurgery, and musculoskeletal care make him the ideal person to drive this next chapter of growth.”
Demetra has been providing orthopaedic solutions for over four decades, improving infection control, prosthesis fixation, and orthobiologics.
The establishment of a US-based division supports Demetra’s goal of expanding its presence in North America, and preparing for international growth.
Demetra Spine aims to enhance surgical outcomes by combining prevention, innovation, and sustainability, reinforcing its vision for the future of spinal surgery.
With the new venture, Demetra aims to extend its impact to spinal surgery, leveraging its robust engineering and technological foundation.
Demetra Spine North America vice president Ted Bird said: “Demetra brings to market an innovative portfolio of surgery-in-a-box procedural kits ready for immediate use in ASC and Hospital operating rooms, designed to increase productivity, decrease the risk of surgical site infections and deliver value by eliminating sterilisation and reprocessing costs.
“Our ambition is to establish a leadership position in the rapidly expanding outpatient spine surgery segment by building a dynamic, market-focused organisation, delivering exceptional products, services, and support to our customers.”
